B. P. Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Saturday, 31st January, 2026 at 11:30 A.M. at the registered office of the company at Plot No-138, Roz Ka Meo Industrial Area, Sohna (Distt. Mewat) Haryana-122103,to inter-alia, consider and approve the Un-Audited Financial Results of the Company & Limited Review Report thereon for the quarter & nine months ended 31st December, 2025 and to carry on any other business with the permission of the Board.
31-Jan-2026
Nath Bio-Genes
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve Financial Results as on 31st December 2025
31-Jan-2026
Yaan Enterprises
Yaan Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results of the Company for the quarter ended on 31st December, 2025
31-Jan-2026
Cont. Securities
Continental Securities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve The allotment of 700000 (Seven Lakh) Equity Shares by conversion of 700000 Warrants (out of the total 2000000 Warrants earlier allotted to the investor) into Equity Shares of face value of ?2/- each at a premium of ?19/- per share on a preferential basis.
31-Jan-2026
Galada Finance
Galada Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve and take on record the Unaudited Financial Results for the quarter ended 31st December 2025 and any other matter with the permission of the Chair.